$14M gross revenue run rate, $10M annually reoccurring. HQ'd in New York City Subscription revenue growing at 65%+ yoy, with over 4x LTV/CAC Team from MIT, Stanford, McKinsey, P&G, Bose & Bain Capital. 4 out of 5 VPs are former founders 4.7 star rating on 9,000+ reviews, $100M+ in saved hearing aid costs, 100,000+ better hearing ears $8B+ market with huge growth tailwinds from recent FDA deregulation towards Over-the-Counter (OTC) High capital efficiency: $7M raised from TIA Ventures, Howzat, Flatiron Health & Onemedical founders At cusp of EBITDA profitability. Projecting cash-flow positive by end of 2024 40%+ of recurring revenue from sticky partnerships with government programs (Veterans, Medicare/aid)